Skip to main content

ARS Pharmaceuticals, Inc.

SPRY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001671858

No open-market purchases or sales by ARS Pharmaceuticals, Inc. insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $726.7M in total; Third Point is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by ARS Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for ARS Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for ARS Pharmaceuticals, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Smith Margaret EkinsChief Commercial Officer–Sep 2, 20261
Casale DonnPresident–Jul 2, 20261
RA Capital Healthcare Fund LPDirector, 10% Owner9,958,073IndirectJun 26, 20261
Ra Capital Management, L.P.Director, 10% Owner9,958,073IndirectJun 26, 20261
Kolchinsky PeterDirector, 10% Owner9,958,073IndirectJun 26, 20261
Shah Rajeev M.Director, 10% Owner9,958,073IndirectJun 26, 20261
RA Capital Nexus Fund II, L.P.Director9,958,073IndirectJun 26, 20261
Schneider Phillip MDirector–Jun 26, 20261
Saunders Brent LDirector0Jun 26, 20261
Thompson Peter A.Director0IndirectJun 26, 20261
Shawver LauraDirector210,346Jun 26, 20261
Islam SaqibDirector–Jun 26, 20261
Shah PratikDirector4,474,554IndirectJun 26, 20262
Dadoo RajeevDirector3,009,677IndirectJun 26, 20261
Kelly MichaelDirector83,225IndirectJun 26, 20261
Fitzpatrick Alexander AChief Legal Officer90,910Jun 12, 20262
Karas EricChief Commercial Officer12,176Jun 12, 20262
Lowenthal Richard EPRESIDENT AND CEO1,196,494IndirectJan 5, 20261
Dorsey BrianChief Operating Officer10,789Jan 5, 20262
Scott Kathleen D.Chief Financial Officer10,042Jan 5, 20261
Chakma JustinChief Business Officer0Jan 5, 20262
Tanimoto SarinaCHIEF MEDICAL OFFICER1,247,447IndirectJan 5, 20261
Deerfield Management Company, L.P.10% Owner4,887,254IndirectJul 1, 20250
Flynn James E10% Owner4,887,254IndirectJul 1, 20250
Deerfield Private Design Fund III, L.P.10% Owner4,887,254IndirectJul 1, 20250
Deerfield Mgmt III, L.P.10% Owner4,887,254IndirectJul 1, 20250
Deerfield Private Design Fund IV, L.P.10% Owner4,887,254IndirectJul 1, 20250
Deerfield Mgmt IV, L.P.10% Owner4,887,254IndirectJul 1, 20250
OrbiMed Advisors LLCDirector0IndirectAug 28, 20240
OrbiMed Capital LLCDirector0IndirectAug 28, 20240
OrbiMed Capital GP VI LLCDirector0IndirectAug 28, 20240
Pratik Shah Living Trust dated June 15, 201110% Owner7,490,404IndirectJun 7, 20240
Root Jonathan DDirector2,364IndirectJun 13, 20220
Capps Vickie LDirector–Jun 13, 20220
Hershberg RobertDirector–Jun 13, 20220
Powell Andrew Kenneth WilliamDirector–Jun 13, 20220
Koehler MariaDirector–Jun 13, 20220
Hawkinson RussSr. Vice President of Finance37,251May 4, 20220
Piazza JonathanChief Financial Officer69,225May 4, 20220
Hunder NaomiChief Medical Officer54,427May 4, 20220
Odegard ValeriePresident and CSO61,639May 4, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 12, 2026 (view filing)Jun 12Same dayKaras EricChief Commercial OfficerSSale−25.0K$10.00−$250.0K−67.2%12.2K after10b5-1
Jun 12, 2026 (view filing)Jun 12Same dayFitzpatrick Alexander AChief Legal OfficerSSale−3.35K$10.00−$33.5K−3.6%90.9K after10b5-1
Nov 14, 2025 (view filing)Nov 122 daysChakma JustinChief Business OfficerSSale−166.4K$8.87−$1.48M−100.0%0 after2 lots
Nov 14, 2025 (view filing)Nov 131 dayDorsey BrianChief Operating OfficerSSale−21.8K$8.71−$190.1K−66.9%10.8K after
Aug 22, 2025 (view filing)Aug 211 dayLowenthal Richard EPRESIDENT AND CEOSSale−50.0K$14.49−$724.5K−4.0%1.20M after10b5-1
Aug 22, 2025 (view filing)Aug 211 dayScott Kathleen D.Chief Financial OfficerSSale−12.5K$15.00−$187.5K−55.5%10.0K after10b5-1
Aug 21, 2025 (view filing)Aug 19-202 daysTanimoto SarinaCHIEF MEDICAL OFFICERSSale−50.0K$14.08−$703.8K−3.9%1.25M after2 lots10b5-1
Jul 3, 2025 (view filing)Jul 12 daysKaras EricChief Commercial OfficerSSale−15.0K$16.99−$254.8K−59.3%10.3K after10b5-1
Jul 1, 2025 (view filing)4:42 PM ETJun 274 daysDeerfield Management Company, L.P. and 5 others10% OwnerSSaleClass A Common Stock−740.1K$18.46−$13.7M−13.2%4.89M after2 lots
Jun 20, 2025 (view filing)Jun 182 daysKaras EricChief Commercial OfficerSSale−15.0K$16.00−$240.0K−66.1%7.70K after10b5-1
May 22, 2025 (view filing)May 202 daysFitzpatrick Alexander AChief Legal OfficerSSale−103.0K$14.10−$1.45M−53.5%89.6K after
May 22, 2025 (view filing)May 202 daysSaunders Brent LDirectorSSale−120.0K$14.25−$1.71M−100.0%0 after
May 22, 2025 (view filing)May 202 daysScott Kathleen D.Chief Financial OfficerSSale−50.0K$14.10−$705.0K−87.1%7.42K after
Apr 8, 2025 (view filing)Apr 71 dayShawver LauraDirectorSSale−50.0K$12.30−$615.0K−19.2%210.3K after10b5-1
Mar 21, 2025 (view filing)Mar 201 dayKaras EricChief Commercial OfficerSSale−10.0K$14.00−$140.0K−56.5%7.70K after10b5-1
Mar 7, 2025 (view filing)Mar 5-62 daysShawver LauraDirectorSSale−50.0K$11.21−$560.4K−19.2%210.3K after2 lots10b5-1
Feb 4, 2025 (view filing)Feb 31 dayShawver LauraDirectorSSale−50.0K$12.31−$615.5K−19.2%210.3K after10b5-1
Jan 7, 2025 (view filing)Jan 61 dayShawver LauraDirectorSSale−50.0K$11.10−$555.0K−19.2%210.3K after10b5-1
Dec 19, 2024 (view filing)Dec 172 daysTanimoto SarinaCHIEF MEDICAL OFFICERSSale−100.0K$11.67−$1.17M−8.3%1.10M after2 lots10b5-1Duplicate filing
Dec 19, 2024 (view filing)Dec 172 daysLowenthal Richard EPRESIDENT AND CEOSSale−100.0K$11.67−$1.17M−8.3%1.10M after2 lots10b5-1
Dec 13, 2024 (view filing)Dec 12-131 dayChakma JustinChief Business OfficerSSale−144.6K$12.23−$1.77M−51.5%136.4K after2 lots
Dec 13, 2024 (view filing)Dec 11-122 daysDorsey BrianChief Operating OfficerSSale−40.0K$12.35−$493.9K−86.9%6.02K after2 lots10b5-1
Dec 12, 2024 (view filing)Dec 102 daysChakma JustinChief Business OfficerSSale−50.0K$13.15−$657.5K−26.8%136.4K after
Dec 11, 2024 (view filing)Dec 101 dayTanimoto SarinaCHIEF MEDICAL OFFICERSSale−100.0K$13.17−$1.32M−8.0%1.15M after2 lots10b5-1Duplicate filing
Dec 11, 2024 (view filing)Dec 101 dayLowenthal Richard EPRESIDENT AND CEOSSale−100.0K$13.17−$1.32M−8.0%1.15M after2 lots10b5-1
Dec 6, 2024 (view filing)Dec 4-62 daysChakma JustinChief Business OfficerSSale−144.6K$14.11−$2.04M−51.5%136.4K after3 lots
Dec 4, 2024 (view filing)Dec 2-32 daysChakma JustinChief Business OfficerSSale−90.0K$13.43−$1.21M−39.8%136.4K after2 lots
Dec 4, 2024 (view filing)Dec 2-42 daysShawver LauraDirectorSSale−200.0K$13.44−$2.69M−48.7%210.3K after4 lots10b5-1
Dec 4, 2024 (view filing)Dec 2-42 daysKaras EricChief Commercial OfficerSSale−10.0K$14.04−$140.4K−63.7%5.69K after2 lots10b5-1
Nov 27, 2024 (view filing)Nov 25-272 daysChakma JustinChief Business OfficerSSale−100.0K$14.12−$1.41M−42.3%136.4K after3 lots
Nov 21, 2024 (view filing)Nov 192 daysLowenthal Richard EPRESIDENT AND CEOSSale−100.0K$13.95−$1.40M−7.7%1.20M after2 lots10b5-1Duplicate filing
Nov 21, 2024 (view filing)Nov 192 daysTanimoto SarinaCHIEF MEDICAL OFFICERSSale−100.0K$13.95−$1.40M−7.7%1.20M after2 lots10b5-1
Nov 14, 2024 (view filing)Nov 122 daysTanimoto SarinaCHIEF MEDICAL OFFICERSSale−100.0K$16.85−$1.68M−7.4%1.25M after4 lots10b5-1Duplicate filing
Nov 14, 2024 (view filing)Nov 122 daysLowenthal Richard EPRESIDENT AND CEOSSale−100.0K$16.85−$1.68M−7.4%1.25M after4 lots10b5-1
Nov 13, 2024 (view filing)8:16 PM ETNov 11-122 daysDeerfield Management Company, L.P. and 5 others10% OwnerSSaleClass A Common Stock−563.3K$18.01−$10.1M−9.7%5.26M after8 lots
Oct 17, 2024 (view filing)Oct 161 dayScott Kathleen D.Chief Financial OfficerSSale−12.5K$16.00−$200.0K−71.6%4.95K after10b5-1
Oct 17, 2024 (view filing)Oct 152 daysTanimoto SarinaCHIEF MEDICAL OFFICERSSale−100.0K$14.88−$1.49M−7.2%1.30M after3 lots10b5-1Duplicate filing
Oct 17, 2024 (view filing)Oct 152 daysLowenthal Richard EPRESIDENT AND CEOSSale−100.0K$14.88−$1.49M−7.2%1.30M after3 lots10b5-1
Oct 10, 2024 (view filing)Oct 82 daysTanimoto SarinaCHIEF MEDICAL OFFICERSSale−100.0K$13.83−$1.38M−6.9%1.35M after2 lots10b5-1Duplicate filing
Oct 10, 2024 (view filing)Oct 82 daysLowenthal Richard EPRESIDENT AND CEOSSale−100.0K$13.83−$1.38M−6.9%1.35M after2 lots10b5-1
Sep 19, 2024 (view filing)Sep 181 dayKaras EricChief Commercial OfficerSSale−10.0K$14.00−$140.0K−63.7%5.69K after10b5-1
Sep 19, 2024 (view filing)Sep 172 daysTanimoto SarinaCHIEF MEDICAL OFFICERSSale−100.0K$12.93−$1.29M−6.7%1.40M after2 lots10b5-1Duplicate filing
Sep 19, 2024 (view filing)Sep 172 daysLowenthal Richard EPRESIDENT AND CEOSSale−100.0K$12.93−$1.29M−6.7%1.40M after2 lots10b5-1
Sep 12, 2024 (view filing)Sep 102 daysTanimoto SarinaCHIEF MEDICAL OFFICERSSale−100.0K$11.50−$1.15M−6.5%1.45M after2 lots10b5-1Duplicate filing
Sep 12, 2024 (view filing)Sep 102 daysLowenthal Richard EPRESIDENT AND CEOSSale−100.0K$11.50−$1.15M−6.5%1.45M after2 lots10b5-1
Aug 28, 2024 (view filing)4:26 PM ETAug 262 daysOrbiMed Advisors LLC and 2 othersDirectorSSale−83.7K$13.00−$1.09M−100.0%0 afterDuplicate filing
Aug 28, 2024 (view filing)Aug 262 daysThompson Peter A.DirectorSSale−83.7K$13.00−$1.09M−100.0%0 after
Aug 23, 2024 (view filing)6:38 PM ETAug 21-232 daysOrbiMed Advisors LLC and 2 othersDirectorSSale−868.7K$13.24−$11.5M−91.2%83.7K after4 lotsDuplicate filing
Aug 23, 2024 (view filing)Aug 21-232 daysThompson Peter A.DirectorSSale−868.7K$13.24−$11.5M−91.2%83.7K after4 lots
Aug 21, 2024 (view filing)Aug 201 dayDorsey BrianChief Operating OfficerSSale−50.0K$15.00−$750.0K−89.2%6.02K after10b5-1